Products
Emerging clinical applications for GLP-1 receptor agonists

This blockbuster drug class has a growing range of mortality implications for underwriting.
Read more
Who We Serve
- Individual Underwriting and Claims Management
- Life Insurance
- Disability Insurance
- Medicare Supplement Insurance
- Long-term Care Insurance
- Post-issue Review
- Business and Agent Monitoring
- Marketing and Prospecting
- Group Underwriting
- Health Insurance
- Life Insurance
- Disability Insurance
- Life Sciences
- Clinical Trials Pre-screening and Enrollment
- - Medicare
  - Medicare Enrollment
- - Risk Adjustment
  - ACA Plans
- - Legal – Mass Tort and Class Action
  - Case Intake Intelligence
ACA risk adjustment leaders: You’re leaving big money on the table

Get it back with a predictive model that improves HCC coding for new members.
Read more
Our Company
Resources and Events
Underwriter Training

Contact Us

Contact Us

Go back

Michael Paczolt, FCAS, MAAA

Principal & Product Manager, Nodal

Michael Paczolt

Milliman IntelliScript^®

Products

Irix^® Suite Irix^® Rules Engine Irix^® Risk Score | Mortality Irix^® Risk Score | Morbidity

Irix^® Data Sets

Prescription Data Medical Data EHR (Electronic Health Records) Criminal Data Credit Data Irix^® ReCheck

Curv^® Suite Curv^® Group Health Curv^® Group Life & Disability Curv^® Market Segmentation Curv^® Risk Adjustment

Our Company

About Us Our Team Meet Our Experts Meet Our Clients Careers Community Giving Newsroom Contact Us

Resources and Events For Consumers Request My Report For Insurance FAQ

Copyright© 2026 Milliman, Inc. All Rights Reserved. Privacy Policy | Terms of Use
Milliman IntelliScript does not make the decision to grant or deny insurance. Milliman IntelliScript is not an insurance company and does not have any information about the insurance company’s decision. Milliman IntelliScript offers consumer reports and related services regulated by the Fair Credit Reporting Act, as well as data, analytics, and additional services that are not consumer reports.